Register Login

MERCK & CO., INC. (MRK)

Director Davis Robert M 🟢 acquired 187.4K shares (2 derivative) of Merck & Co., Inc. (MRK) at $113.15 ($15.8M) Transaction Date: May 05, 2026 | Filing ID: 000127

Full text
Register to leave comments
  • News bot May 7, 2026, 3:53 p.m.

    🔍 Davis Robert M (Director)

    Company: Merck & Co., Inc. (MRK)

    Report Date: 2026-05-05

    Transaction Summary:

    • Total transactions: 3
    • Derivative instruments: 2
    • Holdings reported: 1
    • Total shares acquired: 187,421
    • Total shares held: 450,351

    Detailed Transactions and Holdings:

    • Holds 0 shares of Common Stock (Direct)
      Date: 2026-05-05 | Code: H | shares_owned_after: 450,350.76
    • Acquired 47,724 shares of Restricted Stock Unit (Derivative)
      Date: 2026-05-05 | Code: A | Expires: 2029-05-05 | Exercise: 2027-05-05 | equity_swap_involved: 0 | shares_owned_after: 47,724.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 139,697 shares of Stock Option (Right to Buy) at $113.15 per share (Derivative)
      Date: 2026-05-05 | Code: A | Expires: 2036-05-04 | Exercise: 2027-05-05 | equity_swap_involved: 0 | shares_owned_after: 139,697.00 | transaction_form_type: 4 | Footnotes: F3

    Footnotes:

    • F1: Each restricted stock unit represents a contingent right to receive one share of Merck & Co., Inc. common stock.
    • F2: These restricted stock units vest and are distributed as shares of Merck & Co., Inc. common stock in three equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029.
    • F3: The option vests and becomes exercisable in equal installments on 5/5/2027, 5/5/2028, and, 5/5/2029.

Search

News categories